Antifungal activity of black tea polyphenols (catechins and theaflavins) against candida species

Chemotherapy

Volumn 55, Issue 3, 2009, Pages 189-196

  Sitheeque, M A M ^a   Panagoda, G J ^a   Yau, J ^c   Amarakoon, A M T ^b   Udagama, U R N ^b   Samaranayake, L P ^c  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b TEA RESEARCH INSTITUTE OF SRI LANKA   (Sri Lanka)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antifungal activity; Candida; Post antifungal effect; Tea polyphenols

Indexed keywords

AMPHOTERICIN B; BLACK TEA EXTRACT; CATECHIN; POLYPHENOL DERIVATIVE; THEAFLAVIN;

AGAR DIFFUSION; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONCENTRATION RESPONSE; FUNGUS ISOLATION; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TEA;

ANTIFUNGAL AGENTS; BIFLAVONOIDS; CANDIDA; CATECHIN; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; TEA;

EID: 65449127456     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216836     Document Type: Article

References (29)

1. Zhu QY, Chen ZY:Isolation and analysis of green tea polyphenols by HPLC. Anal Lab 1999;18:70 -72.
2. Subramanian N, Venkatesh P, Ganguli S, Sinkar VP:Role of polyphenol oxidase and peroxidase in the generation of black tea t heaf lavins. J Agric Food Chem 1999;47:2571-2578.
3. Balentine DA:The role of tea flavonoids in cardiovascular health. Proc 2001 Int Conf O-Cha (tea) Culture and Sci, session III, Shizuoka, 2001, pp 84-89.
4. Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishikawa H, Ogawa S, Katsurada M:Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 1996;6:128-133.
5. Osada K, Takahashi M, Hoshina S, Nakamura M, Nakamura S, Sugano M:Tea catechins inhibit cholesterol oxidation accompanying oxidation of low-density lipoprotein in vitro. Comp Biochem Physiol C Toxicol Pharmacol 2001;128:153-164.
6. Shiraki M, Hara Y, Osawa T, Kumon H, Nakayama T, Kawakishi S:Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat Res 1994;323:29-34
7. Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M:Tea catechins and related polyphenols as anti-cancer agents. Biofactors 2000;13:81-85.
8. Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY:Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 2001;131;2248-2251.
9. Otake S, Makimura M, Kuroki T, Nishihara Y, Hirasawa M:Anti-caries effects of polyphenolic compounds from Japanese green tea. Caries Res 1991;25:438-443.
10. Rasheed A, Haider M:Antibacterial activity of Camellia sinensis extracts against dental caries. Arch Pharm Res 1998;21:348-352.
11. Hamilton-Miller JMT:Anti-cariogenic properties of tea (Camellia sinensis). J Med Microbiol 2001;50:299-293.
12. Okubo S, Toda M, Hara Y, Shimamura T:Antifungal and fungicidal activities of tea extract and catechin against Trichophyton (in Japanese, English abstract on Medline). Nippon Saikingaku Zasshi 1991;46:509-514.
13. Samaranayake LP, MacFarlane TW (eds):Oral Candidosis. London, Wright-Butter-worth, 1990.
14. Viviani MA:Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Chemotherapy 1992;38(suppl 1):35-42.
15. Denning DW, Donnelly JP, Hellreigel KP, Ito J, Martino P, van't Wout JW:Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation:what is the state of the art? Ad hoc working group. Chemotherapy 1992;38:43-49.
16. Worthington H V, Clarkson JE:Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy:Cochrane Systematic Review. J Dent Educ 2002;66:903-911.
17. Hirasawa M, Takada K:Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J Antimicrob Chemother 2004;53:225-229.
18. Roberts EAH, Smith RF:The phenolic substances of manufactured tea. IX. The spec-trophotometric evaluation of tea liquors. J Sci Food Agric 1963;14:689.
19. Ellepola ANB, Samaranayake LP:The post-antifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Dis 1998;4:260-267.
20. Samaranayake YH, Ye J, Yau JYY, Cheung BPK, Samaranayake LP:In vitro method to study antif unga l perf usion in Candida biofilms. J Clin Microbiol 2005;43:818-825.
21. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D:Antifungal drug resistance in pathogenic fungi. Med Mycol 1998;36(suppl 1):119-128.
22. Denning DW, Baily GG, Hood SV:Azole resistance in Candida. Eur J Clin Microbiol Infect Dis 1997;16:261-280.
23. Seneviratne CJ, Wong RW, Samaranayake LP:Potent anti-microbial activity of traditional Chinese medicine herbs against Candida species. Mycoses 2008;51:30-34.
24. Wang JL, Chang SC, Hsueh PR, Chen YC:Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002. J Microbiol Immunol Infect 2004;37:236-241.
25. Holm SE, Tornqvist IO, Cars O:Paradoxical effects of antibiotics. Scand J Infect Dis Suppl 1990;74:113-117.
26. Stevens DA, Espiritu M, Parmar R:Paradoxical effect of caspofungin:reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004;48:3407-3411.
27. Odenholt I, Holm SE, Cars O:Effect of antibiotic protein binding on the killing rate of Staphylococcus aureus and on the paradoxical phenomenon. Chemotherapy 1987;33:331-339.
28. Xu YY, Samaranayake YH, Samaranayake LP, Nikawa H:In vitro susceptibility of Candida species to lactoferrin. Med Mycol 1999;37:35-41.
29. Ellepola ANB, Samaranayake LP:Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents. J Oral Pathol Med 1998;27:325-332.